LSV Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $456M | Buy |
18,940,504
+1,649,811
| +10% | +$43.2M | 0.83% | 21 |
|
|
2026
Q1 | $486M | Sell |
17,290,693
-212,021
| -1% | -$5.64M | 1.05% | 13 |
|
|
2025
Q4 | $436M | Buy |
17,502,714
+579,377
| +3% | +$14.6M | 0.95% | 16 |
|
|
2025
Q3 | $431M | Buy |
16,923,337
+773,378
| +5% | +$19.1M | 0.95% | 18 |
|
|
2025
Q2 | $391M | Buy |
16,149,959
+996,845
| +7% | +$23.2M | 0.92% | 18 |
|
|
2025
Q1 | $384M | Buy |
15,153,114
+1,400,622
| +10% | +$36.7M | 0.92% | 19 |
|
|
2024
Q4 | $365M | Buy |
13,752,492
+807,215
| +6% | +$21.9M | 0.84% | 22 |
|
|
2024
Q3 | $375M | Buy |
12,945,277
+1,193,527
| +10% | +$34.8M | 0.8% | 26 |
|
|
2024
Q2 | $329M | Sell |
11,751,750
-603,490
| -5% | -$16.6M | 0.72% | 31 |
|
|
2024
Q1 | $343M | Sell |
12,355,240
-960,500
| -7% | -$26.7M | 0.71% | 33 |
|
|
2023
Q4 | $383M | Sell |
13,315,740
-819,728
| -6% | -$24.8M | 0.84% | 20 |
|
|
2023
Q3 | $469M | Sell |
14,135,468
-458,300
| -3% | -$16.2M | 1.09% | 7 |
|
|
2023
Q2 | $535M | Sell |
14,593,768
-2,693,950
| -16% | -$105M | 1.18% | 6 |
|
|
2023
Q1 | $705M | Sell |
17,287,718
-586,100
| -3% | -$25.3M | 1.58% | 2 |
|
|
2022
Q4 | $916M | Sell |
17,873,818
-1,258,327
| -7% | -$60.3M | 2.02% | 2 |
|
|
2022
Q3 | $837M | Sell |
19,132,145
-203,405
| -1% | -$9.88M | 1.97% | 2 |
|
|
2022
Q2 | $1.01B | Sell |
19,335,550
-1,576,601
| -8% | -$80.3M | 2.19% | 2 |
|
|
2022
Q1 | $1.08B | Sell |
20,912,151
-612,497
| -3% | -$31.8M | 1.99% | 2 |
|
|
2021
Q4 | $1.27B | Sell |
21,524,648
-509,900
| -2% | -$25.3M | 2.25% | 1 |
|
|
2021
Q3 | $948M | Buy |
22,034,548
+195,996
| +0.9% | +$8.68M | 1.71% | 3 |
|
|
2021
Q2 | $855M | Sell |
21,838,552
-675,415
| -3% | -$26.3M | 1.45% | 4 |
|
|
2021
Q1 | $816M | Buy |
22,513,967
+73,099
| +0.3% | +$2.6M | 1.39% | 3 |
|
|
2020
Q4 | $826M | Sell |
22,440,868
-2,740,001
| -11% | -$101M | 1.5% | 3 |
|
|
2020
Q3 | $877M | Sell |
25,180,869
-1,589,327
| -6% | -$55.7M | 1.79% | 3 |
|
|
2020
Q2 | $831M | Sell |
26,770,196
-1,469,276
| -5% | -$49.9M | 1.72% | 4 |
|
|
2020
Q1 | $875M | Sell |
28,239,472
-3,029,975
| -10% | -$103M | 2.11% | 3 |
|
|
2019
Q4 | $1.16B | Sell |
31,269,447
-1,718,970
| -5% | -$61.2M | 1.81% | 4 |
|
|
2019
Q3 | $1.12B | Sell |
32,988,417
-1,359,614
| -4% | -$49.4M | 1.86% | 3 |
|
|
2019
Q2 | $1.41B | Sell |
34,348,031
-1,119,575
| -3% | -$44.5M | 2.27% | 1 |
|
|
2019
Q1 | $1.43B | Sell |
35,467,606
-1,420,476
| -4% | -$56.9M | 2.29% | 1 |
|
|
2018
Q4 | $1.53B | Sell |
36,888,082
-1,819,327
| -5% | -$75.5M | 2.71% | 1 |
|
|
2018
Q3 | $1.62B | Sell |
38,707,409
-53,010
| -0.1% | -$2.04M | 2.42% | 1 |
|
|
2018
Q2 | $1.33B | Buy |
38,760,419
+1,026,066
| +3% | +$35.1M | 2.09% | 1 |
|
|
2018
Q1 | $1.27B | Buy |
37,734,353
+1,518,184
| +4% | +$52.2M | 2.02% | 3 |
|
|
2017
Q4 | $1.24B | Sell |
36,216,169
-86,620
| -0.2% | -$2.95M | 1.96% | 3 |
|
|
2017
Q3 | $1.23B | Buy |
36,302,789
+1,230,336
| +4% | +$39.5M | 2.03% | 2 |
|
|
2017
Q2 | $1.12B | Buy |
35,072,453
+209,852
| +0.6% | +$6.62M | 1.99% | 3 |
|
|
2017
Q1 | $1.13B | Sell |
34,862,601
-1,338,654
| -4% | -$42.2M | 2.06% | 2 |
|
|
2016
Q4 | $1.12B | Sell |
36,201,255
-1,036,227
| -3% | -$31.6M | 2.05% | 3 |
|
|
2016
Q3 | $1.2B | Buy |
37,237,482
+274,567
| +0.7% | +$9.18M | 2.35% | 2 |
|
|
2016
Q2 | $1.23B | Buy |
36,962,915
+1,526,594
| +4% | +$48.7M | 2.53% | 2 |
|
|
2016
Q1 | $997M | Sell |
35,436,321
-3,786,864
| -10% | -$108M | 2.09% | 2 |
|
|
2015
Q4 | $1.2B | Sell |
39,223,185
-1,024,630
| -3% | -$32.2M | 2.61% | 2 |
|
|
2015
Q3 | $1.2B | Sell |
40,247,815
-114,870
| -0.3% | -$3.68M | 2.69% | 1 |
|
|
2015
Q2 | $1.28B | Sell |
40,362,685
-408,355
| -1% | -$13.3M | 2.66% | 1 |
|
|
2015
Q1 | $1.35B | Buy |
40,771,040
+373,402
| +0.9% | +$11.9M | 2.79% | 1 |
|
|
2014
Q4 | $1.19B | Buy |
40,397,638
+1,346,246
| +3% | +$38.6M | 2.48% | 1 |
|
|
2014
Q3 | $1.1B | Buy |
39,051,392
+3,222,693
| +9% | +$90.4M | 2.4% | 1 |
|
|
2014
Q2 | $1.01B | Buy |
35,828,699
+1,604,118
| +5% | +$45.7M | 2.24% | 2 |
|
|
2014
Q1 | $1.04B | Buy |
34,224,581
+4,849,128
| +17% | +$145M | 2.43% | 1 |
|
|
2013
Q4 | $854M | Buy |
29,375,453
+634,857
| +2% | +$18.5M | 2.01% | 4 |
|
|
2013
Q3 | $783M | Sell |
28,740,596
-1,530,458
| -5% | -$41.6M | 2.01% | 4 |
|
|
2013
Q2 | $804M | Buy |
+30,271,054
| New | +$836M | 2.15% | 4 |
|
Other funds holding PFE
LSV Asset Management's PFE Position: Q2 2026 in Review
LSV Asset Management increased its Pfizer (PFE) stake by 9.5% in Q2 2026, buying an estimated $43.2M and bringing the position to 18,940,504 shares worth $456M. The position accounts for 0.83% of the portfolio, ranked #21.
LSV Asset Management first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.62B in Q3 2018. 1,939 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- LSV Asset Management held 18,940,504 shares of Pfizer worth $456M as of Q2 2026.
- LSV Asset Management bought 1,649,811 Pfizer shares in Q2 2026, an estimated $43.2M.
- Pfizer made up 0.83% of LSV Asset Management's portfolio in Q2 2026, its #21 holding.
- LSV Asset Management first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- LSV Asset Management's Pfizer position peaked at $1.62B in Q3 2018.
- 1,939 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on LSV Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.